Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06411912
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-08
Brief Title:
A Study of NIDO-361 in Patients With SBMA
Sponsor:
Nido Biosciences Inc
Organization:
Nido Biosciences Inc
Study Overview
Official Title:
A Phase 2 Randomized Double-Blind Placebo-Controlled Study of NIDO-361 in Patients With Spinal and Bulbar Muscular Atrophy SBMA
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PIONEER KD
Brief Summary:
The purpose of this study is to evaluate the safety tolerability and efficacy of NIDO-361 in adult patients with Spinal and Bulbar Muscular Atrophy SBMA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None